medigraphic.com

2011, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (4)

Evaluation of a rapid immunological test for tuberculosis diagnosis

García-Cruz AE, Olvera-Castillo R, Hernández-Zarza NM, Antuna-Puente B, Uribe-Campero L, Rivas-Ruiz R, González-Canudas J

Language: Spanish
References: 29
Page: 373-379
PDF size: 53.90 Kb.


ABSTRACT

Objective: to evaluate a Mexican rapid immunologic test (PRIM) for pulmonary tuberculosis (PTB).
Methods: a diagnostic test was evaluated at the National Institute of Respiratory Diseases in Mexico City. Class 3 of the American Thorax Society (ATS) for tuberculosis (TB) was considered for PTB. Physical examination, sputum smear, chest X-ray and PRIM were performed to all participants.
Results: a total of 143 patients were included (mean age was 41 years). Seventy two patients were classified as PTB and 71 as latent TB infection (LTBI) or healthy. The sensibility of the rapid immunologic test (RIT) was 79.2 % (CI 95 % = 67.2-87.5), the specificity 100 % (CI 95 % = 93.6-100), Positive predictive value (PV) 100 % (CI 95 % = 92.1-100) and negative PV 82.6 % (CI 95 % = 72.5-89.6). The positive likelihood ratio was 563 (CI 95 % = 1.15-4000.6).
Conclusions: the RIT showed a high sensibility and specificity. Results demonstrate the potential of the RIT for identifying patients with active pulmonary TB.


REFERENCES

  1. Donald PR, van Helden PD. The global burden of tuberculosis– combating drug resistance in difficult times. N Engl J Med 2009;360(4):2393-2396.

  2. World Health Organization. Global tuberculosis control: surveillance, planning and financing. WHO report 2007. Geneva: WHO; 2007. Disponible en http://www.who.int/ tb/publications/global_report/2007/pdf/full.pdf

  3. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. Geneva: WHO; 2009. (Publication no. WHO/HTM/TB/2009. 411).

  4. CENAVECE Epidemiología. México: Dirección General de Epidemiología de la Secretaría de Salud. Boletín epidemiológico Semana 53 (28 de diciembre de 2008 al 3 de enero de 2009.) Disponible en http://www.dgepi.salud.gob. mx/boletin/2008/sem53/

  5. Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345(3):189-200.

  6. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med 2002;347(23):1860-1862.

  7. Pottumarthy S, Wells V, Morris JA. A comparison of seven tests for serological diagnosis of tuberculosis. J Clin Microbiol 2000;38(6):2227-2231. Disponible en http://jcm.asm. org/cgi/reprint/38/6/2227

  8. Lauzardo M, Ashkin D. Phthisiology at the Dawn of the new century. Chest 2000;117(5):1455-1473. Disponible en http://chestjournal.chestpubs.org/content/117/5/1455.long

  9. Soudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70(2):149-159. Disponible en http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2393290/?tool=pubmed

  10. Williams G, Alarcón E, Jittimanee S, Walusimbi M, Sebek M, Berga E, et al. Prácticas óptimas en la atención a los pacientes con tuberculosis. Una guía destinada a países de bajos ingresos. UICTER 2007:13-16.

  11. Watterson SA, Drobniewski FA. Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol 2000;53 (10):727-732.

  12. Porsa E, Cheng L, Seale MM, Delclos GL, Ma X, Reich R, et al. Comparison of a new ESAT-6/CFP-10 peptidebased gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol 2006;13(1):53-58. Disponible en http://cvi.asm.org/cgi/reprint/13/1/53

  13. Grzybowski S. Ontario studies on tuberculin sensitivity. Can J Public Health 1965;56:181-192.

  14. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the wholeblood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293(22):2756-2761. Disponible en http:/ /jama.ama-assn.org/content/293/22/2756.long

  15. Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test. Variability with the mantoux procedure. Am Rev Respir Dis 1985;132(1):175-177.

  16. Pouchot J, Grasland A, Collet C, Coste J, Esdaile JM, Vinceneux P. Reliability of tuberculin skin test measu-rement. Ann Intern Med 1997;126(3):210-214. Disponible en http://www. annals.org/content/126/3/210.full.pdf

  17. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146(5):340-354. Disponible en http://www. annals.org/content/146/5/340.full.pdf+html

  18. Wanchu A, Dong Y, Sethi S, Myneedu VP, Nadas A. Biomarkers for clinical and Incipient tuberculosis: performance in a TB-endemic country. Plos one 2008;3(4):e2071. Disponible en http://www.plosone.org/article/info:doi/10.1371/ journal.pone.0002071

  19. Delacourt C, Gobin J, Gaillard JL, de Blic J, Veron M, Scheinmann P. Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children. Chest 1993;104(2): 393-398. Disponible en http://chestjournal. chestpubs.org/ content/104/2/393.full.pdf+html

  20. Grubek-Jaworska H, Zwolska Z, Droszcz P, Rybus L, Dabrowski A, Droszcz W. Serum and bronchoalveolar IgG against A60 and 38 kDa antigens in the diagnosis of tuberculosis. Int J Tuberc Lung Dis 1997;1(6):556-562.

  21. Demkow U, Filewska M, Michalowska-Mitczuk D, Kus J, Jagodzinski J, Zielonka T, et al. Heterogeneity of antibody response to myobacterial antigens in different clinical manifestations of pulmonary tuberculosis. J Physiol Pharmacol 2007;58 Suppl 5 (Pt 1):117-127. Disponible en http://www.jpp.krakow.pl/ journal/archive/11_07_s5/pdf/117_11_ 07_s5_article.pdf

  22. American Thoracic Society Medical Section of American Lung Association. A Rev Resp Dis 1990;142:725-735.

  23. Mantoux MC. La voie intradermique en tuberculinotherapie. Press Med 1912;20:146-148.

  24. Dunlap N, Bass J, Fujiwara P, Hopewell P, Horsburgh R, Salfinger, Simone P. Diagnostic standards and classification of tuberculosis in adults and children. Am J Resp Crit Care Med 2000;161.(4 Pt 1): 1376-95. Disponible en http://ajrccm.atsjournals.org/cgi/reprint/161/4/1376

  25. Shamsuzzaman AK, Akhter S, Shamsuzzaman SM, Siddique A. Comparison between ELISA and ICT-MycoDot in adult pulmonary tuberculosis. Mymensingh Med J 2006;15(1):33-39.

  26. Bartoloni A, Strohmeyer M, Bartalesi F, Messeri D, Tortoli E, Farese A, et al. Evaluation of a rapid immunochromatographic test for the serologic diagnosis of tuberculosis in Italy. Clin Microbiol Infect 2003;9 (7):632-639. Disponible en http://www.mycobactoscana.it/Testi/sierol.pdf

  27. Ongut G, Ogunc D, Gunseren F, Ogus C, Donmez L, Colak D, et al. Evaluation of the ICT tuberculosis test for the routine diagnosis of tuberculosis. BMC Infect Dis 2006;6:37. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402301/

  28. Howard WL, Klopfenstein MD, Steininger WJ, Woodruff CE. The loss of tuberculin sensitivity in certain patients with active pulmonary tuberculosis. Chest 1970;57(6):530-534. Disponible en http://chestjournal.chestpubs.org/content/57/ 6/530

  29. Talavera JO, Wacher-Rodarte NH, Rivas-Ruiz R. Investigación clínica II. Estudios de proceso (prueba diagnóstica). Rev Med Inst Mex Seguro Soc 2011;49(2):163-170. Disponible en http://201.144.108.128/revista_medica/ index.php?option=com_multicategories&view=article& id=1387: investigacion-clinica-ii-estudios-de-procesoprueba- diagnostica&Itemid=656




2020     |     www.medigraphic.com